ELICIA ARAGON: Open Payments
NPI 1356641724 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,459 in 32 payments from 9 companies in 2025. Trend: 2023 $536 · 2024 $1,572 · 2025 $1,459
Food & beverage: $1,459
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 16 | $927 |
| ABBVIE INC. | 6 | $161 |
| Novartis Pharmaceuticals Corporation | 2 | $127 |
| Galderma Laboratories, L.P. | 1 | $102 |
| Incyte Corporation | 2 | $40 |
| UCB, Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
Products named: DAXXIFY, Rhapsido, BOTOX, OPZELURA, SKYRIZI, Bimzelx, TREMFYA, Zoryve.
Industry payments across NM — which companies pay providers there.
